Workiva heads into its May 28 earnings with a compressed valuation, a short position near multi-month highs, and a wall of analyst target cuts fresh off the tape.
The Street reaction to Tuesday's Q1 results has been swift and one-directional. Both Stifel and BTIG maintained Buy ratings but cut their price targets immediately after the print — Stifel from $79 to $65, BTIG from $90 to $80. That double-cut in a single morning keeps the consensus firmly bullish (10 Buy ratings), but the direction of travel tells a more guarded story. The mean target has compressed to $78.73, roughly 42% above the current $55.41 close, which looks generous on paper until you note that the most recent targets cluster in the $65–$80 range. February saw a similar wave of cuts — Baird to $86, Truist to $90, Stifel to $79 — suggesting a pattern of incremental de-rating that has dragged the Street average down from the $100-plus levels seen late last year. Bulls point to Workiva's AI-powered compliance platform, strong customer retention, and cross-sell momentum. Bears flag that even after a steep slide, the stock trades near 5x EV/Sales and 16x EV/EBITDA — not distressed multiples for a name still finding its earnings footing.
The short position is one of the more meaningful features of this tape. Short interest climbed from roughly 7.1% of the free float in early April to 9.0% now — a move of nearly two full percentage points in about four weeks. That 24% jump in shares short over the past month is the clearest expression of how sentiment shifted ahead of the earnings event. The position has barely moved this week, easing just 0.2% in shares outstanding, which suggests shorts are not rushing to cover after the print. Cost to borrow is not the constraint — at 0.49% annualised, borrowing WK is essentially free — and with shares-to-loan availability still wide, there is no mechanical pressure forcing shorts out of the position.
Options positioning cooled significantly on Tuesday itself. The put/call ratio pulled back to 0.91 after running above 1.40 for four consecutive sessions at the end of April and start of May, close to the 52-week high of 1.64. That sustained defensive hedging into the print has now partially resolved, and the current reading is back closer to the 20-day average of 0.62. The ORTEX short score is 47.8, edging down from above 48 for much of the past two weeks — a modest move, and the score ranks in the 27th percentile for short positioning, suggesting the broader short universe contains names under considerably more pressure than WK.
The founder overhang is worth watching alongside the analyst narrative. Matthew Rizai reduced his stake by 177,409 shares in Q1, leaving him with 4.15% of the company. Co-founder Martin Vanderploeg trimmed by 216,766 shares in the same period. President and COO Julie Iskow has sold in each of the last three months, most recently 7,578 shares in early April at $60. None of these transactions carry the scale of a distress signal, but the consistent direction — every material insider transaction in the data is a sale — adds a layer of context to a stock that has shed 7.7% over the past month and is down sharply from its late-2025 levels.
Among correlated peers, the week showed a wide spread: PCOR dropped 11.9% on its own earnings while AMPL gained 12.6% and FRSH rose 10.9%. WK's 2.3% weekly gain sits comfortably in the middle of that range. The next catalyst is the formal earnings call on May 28 — the degree to which management can address the AI adoption narrative and defend its growth premium will determine whether the target-cutting cycle from the analyst community has further to run.
See the live data behind this article on ORTEX.
Open WK on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
